Neuroone Medical Technologies (NMTC) Return on Capital Employed (2011 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Return on Capital Employed came in at 115.33% in Q1 2026, up 6191.0% YoY from 1.83% in Q1 2025, and down 27.07% on a QoQ basis from 90.76% in Q4 2025.
Neuroone Medical Technologies (NMTC) Return on Capital Employed (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 15 years of Return on Capital Employed data on file, last reported at 115.33% in Q1 2026.
- Quarterly Return on Capital Employed rose 6191.0% year-over-year to 115.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 115.33% (up 6191.0% YoY) and the FY2025 annual result came in at 73.19%, up 18978.0% from the prior year.
- Return on Capital Employed retreated to 115.33% in Q1 2026, from 90.76% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 49.73% in Q3 2025 to a low of 405.98% in Q3 2024.
- A 5-year average of 174.06% and a median of 137.19% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 18117 bps — and 2025, when it jumped 35625 bps.
- Tracing NMTC's Return on Capital Employed over 5 years: stood at 90.91% in 2022, then slumped by 168 bps to 243.18% in 2023, then surged by 36 bps to 155.59% in 2024, then surged by 42 bps to 90.76% in 2025, then decreased by 27 bps to 115.33% in 2026.
- The last three Return on Capital Employed figures came in at 115.33% (Q1 2026), 90.76% (Q4 2025), and 49.73% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 12.08% |
| 10 | Neuroone Medical Technologies | 19.40 Mn | 17.35 Mn | 1.18 Mn | -163.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -163.36% |
| Mar 31, 2026 | -115.33% |
| Dec 31, 2025 | -90.76% |
| Sep 30, 2025 | -49.73% |
| Jun 30, 2025 | -91.31% |
| Mar 31, 2025 | -177.24% |
| Dec 31, 2024 | -155.59% |
| Sep 30, 2024 | -405.98% |
| Jun 30, 2024 | -353.33% |
| Mar 31, 2024 | -318.36% |
| Dec 31, 2023 | -243.18% |
| Sep 30, 2023 | -232.81% |
| Jun 30, 2023 | -215.28% |
| Mar 31, 2023 | -137.19% |
| Dec 31, 2022 | -90.91% |
| Sep 30, 2022 | -110.25% |
| Jun 30, 2022 | -93.84% |
| Mar 31, 2022 | -77.89% |
| Dec 31, 2021 | -94.66% |
| Sep 30, 2021 | -132.84% |